About
Christina Lee Chung, MD, FAAD is a board-certified dermatologist and former Associate Professor of Dermatology at Drexel University. She is CEO of Hayflick Therapeutics, a development-stage biotechnology company focused on topical rapamycin and healthspan, and Hayflick credits her as part of the founding team behind its clinical and translational strategy. She is also publicly described by WatchUFA as a co-owner of the Philadelphia Phoenix professional ultimate team.
Areas of interest
longevitybiotechdermatologyskin cancertransplant dermatologyaging biologymTOR biologyhealthspanaestheticssports